Search research articles
Contact Us
Filters
Showing results (261-270 of 394) with videos related to
Page
of 40
Sort By:
Dermatology and Therapy
|
July 15, 2024
The Impact of Lebrikizumab on Vaccine-Induced Immune Responses: Results from a Phase 3 Study in Adult Patients with Moderate-to-Severe Atopic Dermatitis
Jennifer Soung, Vivian Laquer, Joseph F Merola, et al.
Dermatology (Basel, Switzerland)
|
January 29, 2020
Examination of Treatment Satisfaction Instruments in Psoriasis: 2017 Results from the Psoriasis Working Group of the International Dermatology Outcome Measures (IDEOM)
Heather Kornmehl, Kristina Callis Duffin, Nicole Salame, et al.
Journal of the American Academy of Dermatology
|
January 1, 2026
Clarifying Psoriasis Disease Severity: A Position Statement from the National Psoriasis Foundation Medical Board
Andrew Blauvelt, Ronald Prussick, Joseph F Merola, et al.
Dermatology and Therapy
|
December 11, 2025
Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 Year
Diamant Thaçi, Akihiko Asahina, Wolf-Henning Boehncke, et al.
The Journal of Rheumatology
|
August 15, 2023
Screening and Referral Strategies for the Early Recognition of Psoriatic Arthritis Among Patients With Psoriasis: Results of a GRAPPA Survey
Kaiyang Song, Louisa Webb, Lihi Eder, et al.
American Journal of Clinical Dermatology
|
January 18, 2020
Investigator and Patient Global Assessment Measures for Psoriasis Clinical Trials: A Systematic Review on Measurement Properties from the International Dermatology Outcome Measures (IDEOM) Initiative
Lourdes M Perez-Chada, Nicole F Salame, Adam R Ford, et al.
Dermatology and Therapy
|
February 10, 2024
The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel
Joshua Burshtein, Milaan Shah, Danny Zakria, et al.
Dermatology and Therapy
|
February 7, 2025
Deucravacitinib: Adverse Events of Interest Across Phase 3 Plaque Psoriasis Trials
Joseph F Merola, Laura K Ferris, Jeffrey M Sobell, et al.
The Journal of Clinical and Aesthetic Dermatology
|
October 24, 2024
Diagnostic Delay of Psoriatic Arthritis of More Than Six Months Contributes to Poor Patient-Reported Outcome Measures in Depression, Social Ability, and Disease Impact: A Cross-sectional Study
Melissa P Zundell, Lourdes Perez-Chada, Neel Tapryal, et al.
The Journal of Rheumatology
|
December 1, 2025
Validity and Psychometric Properties of 3 and 4 Visual Analog Scale in Participants With Psoriatic Arthritis Treated With Guselkumab
William Tillett, Laura C Coates, Marijn Vis, et al.
Page
of 40
Search research articles
Search
Showing results (261-270 of 394) with videos related to
Sort By:
Page
of 40
Dermatology and Therapy
|
July 15, 2024
The Impact of Lebrikizumab on Vaccine-Induced Immune Responses: Results from a Phase 3 Study in Adult Patients with Moderate-to-Severe Atopic Dermatitis
Jennifer Soung, Vivian Laquer, Joseph F Merola, et al.
Dermatology (Basel, Switzerland)
|
January 29, 2020
Examination of Treatment Satisfaction Instruments in Psoriasis: 2017 Results from the Psoriasis Working Group of the International Dermatology Outcome Measures (IDEOM)
Heather Kornmehl, Kristina Callis Duffin, Nicole Salame, et al.
Journal of the American Academy of Dermatology
|
January 1, 2026
Clarifying Psoriasis Disease Severity: A Position Statement from the National Psoriasis Foundation Medical Board
Andrew Blauvelt, Ronald Prussick, Joseph F Merola, et al.
Dermatology and Therapy
|
December 11, 2025
Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 Year
Diamant Thaçi, Akihiko Asahina, Wolf-Henning Boehncke, et al.
The Journal of Rheumatology
|
August 15, 2023
Screening and Referral Strategies for the Early Recognition of Psoriatic Arthritis Among Patients With Psoriasis: Results of a GRAPPA Survey
Kaiyang Song, Louisa Webb, Lihi Eder, et al.
American Journal of Clinical Dermatology
|
January 18, 2020
Investigator and Patient Global Assessment Measures for Psoriasis Clinical Trials: A Systematic Review on Measurement Properties from the International Dermatology Outcome Measures (IDEOM) Initiative
Lourdes M Perez-Chada, Nicole F Salame, Adam R Ford, et al.
Dermatology and Therapy
|
February 10, 2024
The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel
Joshua Burshtein, Milaan Shah, Danny Zakria, et al.
Dermatology and Therapy
|
February 7, 2025
Deucravacitinib: Adverse Events of Interest Across Phase 3 Plaque Psoriasis Trials
Joseph F Merola, Laura K Ferris, Jeffrey M Sobell, et al.
The Journal of Clinical and Aesthetic Dermatology
|
October 24, 2024
Diagnostic Delay of Psoriatic Arthritis of More Than Six Months Contributes to Poor Patient-Reported Outcome Measures in Depression, Social Ability, and Disease Impact: A Cross-sectional Study
Melissa P Zundell, Lourdes Perez-Chada, Neel Tapryal, et al.
The Journal of Rheumatology
|
December 1, 2025
Validity and Psychometric Properties of 3 and 4 Visual Analog Scale in Participants With Psoriatic Arthritis Treated With Guselkumab
William Tillett, Laura C Coates, Marijn Vis, et al.
Page
of 40